Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein

Journal of General Virology

Volumn 78, Issue 1, 1997, Pages 107-111

  Wild, T Fabian ^a   Buckland, Robin ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE ZIPPER PROTEIN; SYNTHETIC PEPTIDE; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CELL FUSION; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; MEASLES; MEASLES VIRUS; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS CELL INTERACTION;

ANIMALIA; CANINE DISTEMPER VIRUS; DISTEMPER VIRUS; MEASLES VIRUS; MUMPS VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0031022688     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-1-107     Document Type: Article

References (15)

1. Buckland, R. & Wild, T. F. (1989). Leucine zipper motif extends. Nature 547, 6216.
2. Buckland, R., Gerald, C., Barker, R. & Wild, T. F. (1987). Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses. Journal of General Virology 68, 1695-1703.
3. Buckland, R., Malvoisin, E., Beauverger, P. & Wild, T. F. (1992). A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. Journal of General Virology 73, 1703-1707.
4. Giraudon, P. & Wild, T. F. (1985). Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
5. Horta-Barbosa, L. R., Hamilton, B., Wittig, B., Fucillo, P. & Sever, J. L. (1971). Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science 173, 840-841.
6. Hull, J. D., Krah, D. L. & Choppin, P. W. (1987). Resistance of a measles virus mutant to fusion inhibitory oligopeptides is not associated with mutations in the fusion peptide. Virology 159, 368-372.
7. Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G. & Petteway, S. R., Jr (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proceedings of the National Academy of Sciences. USA 93, 2186-2191.
8. Malvoisin, E. & Wild, T. F. (1990). Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. Journal of Virology 164, 5160-5162.
9. Matthews, T. J., Wild, C., Chen, C. H., Bolognesi, D. P. & Greenberg, M. (1994). Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunological Reviews 140, 93-104.
10. Norrby, E. (1971). The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology 44, 599-608.
11. Richardson, C. D., Scheid, A. & Choppin, P. W. (1980). Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology 105, 205-222.
12. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B. & Matthews, T. J. (1994). Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proceedings of the National Academy of Sciences, USA 91, 9770-9774.
13. Wild, T. F. & Huppert, J. (1980). Specificity of measles virus and canine distemper virus antibodies. Annals of Virology 131, 73-84.
14. Wild, T. F., Bernard, A., Spehner, D. & Drillien, R. (1992). Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Journal of General Virology 73, 359-367.
15. Wild, T. F., Fayolle, J., Beauverger, P. & Buckland, R. (1994). Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein. Journal of Virology 68, 7546-7548.